Compound 1020
Identifiers
- Canonical SMILES:
CNc1nc(NCc2ccc(NC(=O)c3cccc(Cl)n3)cc2)c2ccccc2n1
- InChi:
InChI=1S/C22H19ClN6O/c1-24-22-28-17-6-3-2-5-16(17)20(29-22)25-13-14-9-11-15(12-10-14)26-21(30)18-7-4-8-19(23)27-18/h2-12H,13H2,1H3,(H,26,30)(H2,24,25,28,29)
- InChiKey:
DTDHAVMTRCRSNB-UHFFFAOYSA-N
External links
168318085 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Beta-catenin / TCF-4 | 6.01 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 418.13 g/mol | |||
HBA | 7 | |||
HBD | 3 | |||
HBA + HBD | 10 | |||
AlogP | 4.45 | |||
TPSA | 91.83 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6014 | 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide | DB07315 | |
0.5363 | Vistusertib | DB11925 | |
0.5220 | Dabigatran | DB14726 | |
0.5071 | 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide | DB03082 | |
0.4974 | Pagoclone | DB04903 | |
0.4938 | FG-2216 | DB08687 | |
0.4820 | Defactinib | DB12282 | |
0.4813 | Aminopterin | DB08878 | |
0.4813 | Methotrexate | DB00563 | |
0.4796 | BMS-919373 | DB15047 | |
0.4794 | Talotrexin | DB06178 | |
0.4778 | 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | DB06938 | |
0.4774 | Sri-9439 | DB03351 | |
0.4774 | Duvelisib | DB11952 | |
0.4759 | Mocetinostat | DB11830 |